Two new studies suggest that pediatric medulloblastomas and high-grade gliomas are genetically different from the same tumors in adults. Age-dependent gene expression might affect tumor biology; therefore, therapies for adult medulloblastomas or gliomas might not produce the same clinical outcomes in pediatric patients, and vice versa.
References
Korshunov, A. et al. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J. Clin. Oncol. 28, 3054–3060 (2010).
Paugh, B. S. et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J. Clin. Oncol. 28, 3061–3068 (2010).
Brandes, A. A. et al. The treatment of adults with medulloblastoma: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 57, 755–761 (2003).
Gururangan, S. et al. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J. Clin. Oncol. 28, 3069–3075 (2010).
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).
Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008).
Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A. A. Brandes has acted as a consultant for Bristol-Myers Squibb, OncoMethylome Sciences, Roche and Schering-Plough. She has also received honoraria for lectures from GlaxoSmithKline, Roche and Schering-Plough. E. Franceschi declares no competing interests.
Rights and permissions
About this article
Cite this article
Brandes, A., Franceschi, E. Genetic variation in pediatric and adult brain tumors. Nat Rev Neurol 6, 653–654 (2010). https://doi.org/10.1038/nrneurol.2010.176
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.176
- Springer Nature Limited
This article is cited by
-
Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
Journal of Neuro-Oncology (2016)